Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer.

Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer. Oncotarget. 2018 Nov 27;9(93):36547-36548 Authors: Ghiringhelli F, Truntzer C PMID: 30564294 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research